Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 16, 2021

BUY
$41.43 - $77.09 $310,725 - $578,175
7,500 Added 83.33%
16,500 $1.2 Million
Q2 2019

Aug 14, 2019

SELL
$25.78 - $39.77 $232,020 - $357,930
-9,000 Reduced 50.0%
9,000 $324,000
Q1 2019

May 15, 2019

BUY
$22.09 - $39.21 $397,620 - $705,780
18,000 New
18,000 $568,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.25B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.